Seeking Alpha

Illumina (ILMN) rises 1% AH after declaring Roche's $44.50/share hostile bid to be inadequate,...

Illumina (ILMN) rises 1% AH after declaring Roche's $44.50/share hostile bid to be inadequate, and calling the offer's timing "blatantly opportunistic." Given that Illumina closed today at $51.80, such a response was widely expected. Two weeks ago, Illumina adopted a poison pill in response to Roche's offer.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector